Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)

Choi Min Chul; Lim Myong Cheol; Suh Dong Hoon; Song Yong Jung; Kim Tae-Joong; Chang Suk-Joon; Kim Jae-Weon; Korean Society of Gynecologic Oncology

首页> 外文期刊>Journal of Gynecologic Oncology >Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)

【24h】

Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)

机译：腹膜癌，卵巢癌和输卵管癌基因检测的立场声明：韩国妇科肿瘤学会（KSGO）

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Gynecologic Oncology》 |2016年第4期|共页
作者
Choi Min Chul; Lim Myong Cheol; Suh Dong Hoon; Song Yong Jung; Kim Tae-Joong; Chang Suk-Joon; Kim Jae-Weon; Korean Society of Gynecologic Oncology;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology [J] . Kong Tae-Wook, Kim Miseon, Kim Young-Han, Journal of Gynecologic Oncology . 2020,第1期

机译：高风险的人乳头瘤病毒检测作为宫颈癌的主要筛查：韩国妇产科和韩国妇科肿瘤学会的立场声明
2. Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement [J] . Kim Miseon, Kong Tae-Wook, Kim Sunghoon, Journal of Gynecologic Oncology . 2019,第5期

机译：宫颈癌女性进行彻底子宫切除术的微创手术：韩国妇科肿瘤学会，韩国妇产科学会，韩国妇科内窥镜和微创手术学会立场声明
3. Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer [J] . Komiyama Shinichi, Katabuchi Hidetaka, Mikami Mikio, International journal of clinical oncology . 2016,第3期

机译：日本妇科肿瘤学会2015年指南，用于治疗包括原发性腹膜癌和输卵管癌在内的卵巢癌
4. Evaluation of a Clinical Decision Support System for the Prescription of Genetic Tests in the Gynecological Cancer Risk [C] . Jesús Moreno-Conde, Celia Alvarez-Romero, Cristina Suárez-Mejías, MEDINFO . 2019

机译：评价妇科癌症风险中遗传检测处方的临床决策支持系统
5. Dolo?anje Mutacij v Genih BRCA1/2 Iz citolo?kega Materiala Pri Raku jaj?nikov, Jajcevodov in Primarnem Peritonealnem Seroznem Karcinomu =BRCA1/2 mutation testing from cytological samples in patients with ovarian, tubal and primary peritoneal serous cancer [D] . Gornjec, Andreja. 2020

机译：从自我癌症中确定基因Krca1 / 2中的突变吗？
6. Position statements on genetic test for peritoneal ovarian and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO) [O] . Min Chul Choi, Myong Cheol Lim, Dong Hoon Suh, 2016

机译：腹膜癌卵巢癌和输卵管癌基因检测的立场声明：韩国妇科肿瘤学会（KSGO）
7. Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG) [O] . Miseon Kim, Young-Han Kim, Yong Beom Kim, 2018

机译：平均风险降低妇女卵巢/输卵管/腹膜癌的双侧蝾螈：韩国妇产科和妇科的立场声明（ksog）

Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)

著录项

相似文献

相关主题

期刊订阅